You have 9 free searches left this month | to do more

everolimus

Everolimus is a drug used to treat Breast Cancer, Neuroendocrine Tumors, Renal Cell Carcinoma, and other conditions. Everolimus is being actively studied in 84 studies and prior, has been studied in 240.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative SiteHelio Tedesco Silva Junior
M.D. Anderson Cancer CenterMemorial Sloan Kettering Cancer CenterIngrid Mayer, MD
National Cancer Institute (NCI)Dana-Farber Cancer InstituteTaofeek K. Owonikoko
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • Everolimus
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-12-16
Dec 16, 2021
N
Completed
  • Brain Tumor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-07
Jan 7, 2022
Y
Terminated
  • Breast Cancer
  • Everolimus
  • New Haven, Connecticut
    Yale University
2022-01-12
Jan 12, 2022
Y
Recruiting
  • Renal Cell Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
2021-12-13
Dec 13, 2021
U
Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
2021-11-03
Nov 3, 2021
F
Not yet recruiting
  • Renal Cell Carcinoma
  • Anlotinib hydrochloride
  • everolimus
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
2021-11-05
Nov 5, 2021
T
Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
2021-10-18
Oct 18, 2021
U
Recruiting
  • Classical Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-07-23
Jul 23, 2021
E
Completed
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
2021-11-19
Nov 19, 2021
S
Completed
  • Breast Cancer
  • Everolimus
  • +4 more
  • Guangzhou, Guangdong, China
    Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
2021-09-22
Sep 22, 2021
N
Completed
  • Epilepsy
  • +2 more
  • Everolimus
  • New York, New York
    New York University Langone Medical Center
2021-08-31
Aug 31, 2021
A
Active, not recruiting
  • Breast Cancer
  • Ovarian Cancer
  • Sioux Falls, South Dakota
    Avera Cancer Institute
2021-08-24
Aug 24, 2021
U
Terminated
  • Breast Neoplasms
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
2022-02-09
Feb 9, 2022
H
Completed
  • Kidney Transplant Infection
  • São Paulo, Sao Paulo, Brazil
    Hospital do Rim
2021-08-23
Aug 23, 2021
S
Active, not recruiting
  • Glioblastoma Multiforme
  • Glioma of Brain
  • Chandler, Arizona
  • +2 more
2022-03-10
Mar 10, 2022
T
Suspended
  • Thyroid Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-10-07
Oct 7, 2021
M
Completed
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-06-29
Jun 29, 2021
U
Active, not recruiting
  • Recurrent Childhood Ependymoma
  • Everolimus
  • Stanford, California
  • +3 more
2022-01-31
Jan 31, 2022
M
Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-06-15
Jun 15, 2021
H
Withdrawn
  • Facial Angiofibromas
  • Everolimus
  • Placebo
  • Bron, France
    Hopital Femme Mère Enfant
2021-04-28
Apr 28, 2021
N
Not yet recruiting
  • Renal Angiomyolipoma
  • Everolimus
  • (no location specified)
2022-02-16
Feb 16, 2022
M
Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-19
Oct 19, 2021
W
Terminated
  • Adenocarcinoma
  • Pancreatic Neoplasms
  • Saint Louis, Missouri
  • +1 more
2021-06-15
Jun 15, 2021